OWKIN

We're launching a comprehensive multimodal patient data discovery program with 20 leading healthcare institutions across France, Spain, Germany, Italy, the US, the UK, and Israel to accelerate medical research by breaking down data silos. This program will map 11 therapeutic areas across Owkin's extensive transatlantic network, enhancing AI research, advancing disease understanding, and supporting the improvement of patient outcomes globally. The program includes the following centers: Cooper University Health Care, Fundació Institut d'Investigació Sanitària Illes Balears (IdISBa), Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, Javier Hernández Losa, CuriMeta, Inc., Washington University School of Medicine in St. Louis, Institut d'Investigació Biomèdica de Girona (IDIBGI), The Royal Marsden NHS Foundation Trust, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Leipzig University, Sheba Medical Center, Tel Hashomer, Aster Insights, Navarrabiomed - Centro de Investigación Biomédica. 📰 Read more at: https://lnkd.in/eUujbN5k

Missed our webinar on spatial biology and AI in targeted therapy? No fret, you can now watch it on demand. 🎥 Our experts from Owkin and 10x Genomics, Atanas Kamburov and Trisha Bartlett, explored how spatial omics and AI can accelerate antibody-drug conjugate (ADC) development, driving novel discoveries in precision medicine. Watch the full webinar now → https://lnkd.in/erCtmr6h

AI, data & biotech: How is this game-changing trio redefining medicine? Find out at HumanX on March 12, where Owkin's CEO Thomas Clozel joins Nabla's Co-founder and COO, Delphine Groll, and Ian Krietzberg as the moderator, to explore AI’s role in driving faster clinical trials, smarter patient care, and medical innovations. Learn more about the conference → https://www.humanx.co/

🧬 Can spatial biology and AI transform antibody-drug conjugates (ADC) clinical development? Next Tuesday at the World ADC conference in London, Owkin’s Jonas Béal will deliver a talk to showcase how our MOSAIC research dataset—the world’s largest spatial and multi-omics dataset in oncology—and advanced AI models unlock tumor heterogeneity, biomarker discovery & smarter treatment strategies. Book a meeting to discuss how Owkin can optimize your ADCs with Aurélie Fugon and Ariane Peyret, PhD → calendly.com/aureliefugon

Looking back at our glioblastoma moonshot hackathon, we dive into the solutions proposed by the three winning projects: 🔬 Clinical award: Team Glioblasters – Using spatial and multi-omics data to map tumor-immune interactions. 🤖 AI Methodology Award: Team J – Building a multimodal AI framework to predict patient outcomes. 🏆 Special Jury Award: Team SpaceAix – Integrating AI & multi-omics to trace disease progression and identify biomarkers. Read the blog to explore the solutions in more detail. https://lnkd.in/eZAkCWYs

Check out the latest from Owkin in February 🌐 📰 Dive into this month’s top highlights from Owkinews. Discover the latest in healthcare breakthroughs and groundbreaking research, your source for all the must-know news. 📬 Stay connected, subscribe now to be part of our journey of transforming healthcare innovation.

Last chance to reserve your spot ⏰ Join us tomorrow at 11 AM EDT / 5 PM CET for an exclusive webinar on spatial biology & AI in targeted therapy, co-hosted with 10x Genomics. 🔬 Our experts will explore how spatial omics and AI can accelerate antibody-drug conjugate (ADC) development, driving novel discoveries in precision medicine. 🎙 Speakers: Atanas Kamburov, Head of Pharma Solutions Data Science, Owkin Trisha Bartlett, Associate Director Strategic Marketing, 10x Genomics 🔗 Register now: https://lnkd.in/erCtmr6h

💊 How can AI help identify the best biomarkers to turn biological data into actionable insights? Our CEO & Co-founder, Thomas Clozel, sits down with 👉 Franck Sebag on EY’s "Grow Fast, Now What?" podcast to share his journey from a cancer doctor to an entrepreneur, and how AI is unlocking biological data to reimagine healthcare. 🇫🇷 Tune in: https://lnkd.in/e2uSYXfS

🔍 How can AI unlock a deeper understanding of a patient's disease? 🇫🇷 Our Chief Diagnostic Officer, Meriem Sefta, dives into the topic with Cécile Hellouin de Menibus and Nicolas Leroy on Sud Radio's "Les vraies voix de l'emploi". Meriem explores how AI is reshaping precision medicine: its breakthroughs, opportunities, and challenges, and addresses the need for ethical and societal reflection on AI employment. Joining her are Axel Dauchez, CEO of Make.org, and Stéphanie Delestre, CEO of Volubile. Watch it here → https://lnkd.in/eDPATQg4

Our Senior VP of Partnerships Agathe Arlotti joins Hélène Sagnes for an interview on Les Echos Etudes to talk about Owkin’s mission: harnessing human expertise and AI to fast-track better treatments for patients. Owkin works with leading partners to meet urgent unmet medical needs, reimagining the future of medicine. Read the piece → https://lnkd.in/erUDYCtt